These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37829518)

  • 1. Retracted: Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9756164. PubMed ID: 37829518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis.
    Bose B; Chung EYM; Hong R; Strippoli GFM; Johnson DW; Yang WL; Badve SV; Palmer SC
    J Nephrol; 2022 May; 35(4):1159-1170. PubMed ID: 35199314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of idiopathic membranous nephropathy in adults: KDIGO 2012, cyclophosphamide and cyclosporine A are out, rituximab is the new normal.
    Rojas-Rivera JE; Carriazo S; Ortiz A
    Clin Kidney J; 2019 Oct; 12(5):629-638. PubMed ID: 31583088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis.
    Lu W; Gong S; Li J; Luo H; Wang Y
    Medicine (Baltimore); 2020 Apr; 99(16):e19804. PubMed ID: 32311997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
    Fervenza FC; Canetta PA; Barbour SJ; Lafayette RA; Rovin BH; Aslam N; Hladunewich MA; Irazabal MV; Sethi S; Gipson DS; Reich HN; Brenchley P; Kretzler M; Radhakrishnan J; Hebert LA; Gipson PE; Thomas LF; McCarthy ET; Appel GB; Jefferson JA; Eirin A; Lieske JC; Hogan MC; Greene EL; Dillon JJ; Leung N; Sedor JR; Rizk DV; Blumenthal SS; Lasic LB; Juncos LA; Green DF; Simon J; Sussman AN; Philibert D; Cattran DC;
    Nephron; 2015; 130(3):159-68. PubMed ID: 26087670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab In The Treatment Of Refractory Idiopathic Membranous Nephropathy In Pakistani Population.
    Anjum N; Nabi Z; Alam MA
    J Ayub Med Coll Abbottabad; 2019; 31(2):265-268. PubMed ID: 31094128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of efficacy of rituximab for membranous nephropathy: A systematic review and meta-analysis of 11 studies.
    Ou JY; Chen YW; Li TL; Shan HZ; Cui S; Lai JJ; Xiao Y
    Nephrol Ther; 2022 Apr; 18(2):104-112. PubMed ID: 35074299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience.
    Chen P; Mao M; Wang C; Zhang X; Zhao X; Gao Y; Luo Y; Zhou Y
    Front Endocrinol (Lausanne); 2023; 14():1044782. PubMed ID: 36875477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Safety and Efficacy of Rituximab-Based Regimen in Atypical Membranous Nephropathy: A Single Center Retrospective Cohort Study.
    Liu Y; Zhang S; Hu R; Li C; Chen G; Shi X; Liu Y; Zheng K; Li H; Wen Y; Li X; Li X; Xia P; Qin Y
    Int J Gen Med; 2023; 16():1983-1993. PubMed ID: 37251282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic membranous nephropathy in children treated with rituximab: report of two cases.
    Malatesta-Muncher R; Eldin KW; Beck LH; Michael M
    Pediatr Nephrol; 2018 Jun; 33(6):1089-1092. PubMed ID: 29546599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.
    Cortazar FB; Leaf DE; Owens CT; Laliberte K; Pendergraft WF; Niles JL
    BMC Nephrol; 2017 Feb; 18(1):44. PubMed ID: 28143416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Efficacy of Rituximab in the Treatment of Membranous Nephropathy.
    Maharjan R; Wang JW; Shrestha IK
    J Nepal Health Res Counc; 2021 Jan; 18(4):580-587. PubMed ID: 33510493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis.
    Chen M; Zhang X; Xiong Y; Xu G
    Int Urol Nephrol; 2023 Mar; 55(3):641-651. PubMed ID: 36161550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Efficacy and Safety of Glycosides of Tripterygium wilfordii Combined with Renin-Angiotensin System in the Treatment of IgA Nephropathy: A Systematic Review and Meta-Analysis.
    International EM
    Emerg Med Int; 2023; 2023():9814961. PubMed ID: 37593429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of idiopathic membranous nephropathy treated with rituximab.
    Young Yoon J; Tae Han S; Cho A; Ryoun Jang H; Eun Lee J; Huh W; Joong Kim D; Young Oh H; Kim YG
    Kidney Res Clin Pract; 2013 Sep; 32(3):138-41. PubMed ID: 26877930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis.
    Lu H; Shen J; Sun J; Sun J
    Appl Bionics Biomech; 2022; 2022():5393797. PubMed ID: 36276580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Efficacy and Safety of Jinshuibao Capsule in Diabetic Nephropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9813031. PubMed ID: 38094458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab for the management of idiopathic membranous nephropathy: a meta-analysis.
    Huang L; Dong QR; Zhao YJ; Hu GC
    Int Urol Nephrol; 2021 Jan; 53(1):111-119. PubMed ID: 32944889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial.
    Scolari F; Delbarba E; Santoro D; Gesualdo L; Pani A; Dallera N; Mani LY; Santostefano M; Feriozzi S; Quaglia M; Boscutti G; Ferrantelli A; Marcantoni C; Passerini P; Magistroni R; Alberici F; Ghiggeri GM; Ponticelli C; Ravani P;
    J Am Soc Nephrol; 2021 Apr; 32(4):972-982. PubMed ID: 33649098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy.
    Cravedi P; Ruggenenti P; Sghirlanzoni MC; Remuzzi G
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):932-7. PubMed ID: 17702725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.